These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 27932882

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Development of artemether and lumefantrine co-loaded nanostructured lipid carriers: physicochemical characterization and in vivo antimalarial activity.
    Parashar D, Aditya NP, Murthy RS.
    Drug Deliv; 2016; 23(1):123-9. PubMed ID: 24786480
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
    Rashidzadeh H, Salimi M, Sadighian S, Rostamizadeh K, Ramazani A.
    Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem) for bioequivalence in a randomized, open-label, two-period study.
    Lefèvre G, Bhad P, Jain JP, Kalluri S, Cheng Y, Dave H, Stein DS.
    Malar J; 2013 Sep 08; 12():312. PubMed ID: 24010572
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children.
    Abdulla S, Sagara I.
    Malar J; 2009 Oct 12; 8 Suppl 1(Suppl 1):S7. PubMed ID: 19818174
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Coartem: the journey to the clinic.
    Premji ZG.
    Malar J; 2009 Oct 12; 8 Suppl 1(Suppl 1):S3. PubMed ID: 19818170
    [Abstract] [Full Text] [Related]

  • 17. Ameliorating the in vivo antimalarial efficacy of artemether using nanostructured lipid carriers.
    Vanka R, Kuppusamy G, Praveen Kumar S, Baruah UK, Karri VVSR, Pandey V, Babu PP.
    J Microencapsul; 2018 Mar 12; 35(2):121-136. PubMed ID: 29448884
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.
    Fule R, Dhamecha D, Maniruzzaman M, Khale A, Amin P.
    Int J Pharm; 2015 Dec 30; 496(1):137-56. PubMed ID: 26471056
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.